Correlation of integrity of cone outer segment tips line with retinal sensitivity after half-dose photodynamic therapy for chronic central serous chorioretinopathy.
Fujita, Kyoko; Shinoda, Kei; Imamura, Yutaka; Matsumoto, Celso Soiti; Mizutani, Yoshihiro; Mizota, Atsushi; Yuzawa, Mitsuko.
Am J Ophthalmol
; 154(3): 579-85, 2012 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-22818904
Angiographic and Tomographic Prognostic Factors of Chronic Central Serous Chorioretinopathy Treated with Half-Dose Photodynamic Therapy.
COMPARISON OF PHOTODYNAMIC THERAPY USING HALF-DOSE OF VERTEPORFIN OR HALF-FLUENCE OF LASER LIGHT FOR THE TREATMENT OF CHRONIC CENTRAL SEROUS CHORIORETINOPATHY.
Detection of morphologic alterations by spectral-domain optical coherence tomography before and after half-dose verteporfin photodynamic therapy in chronic central serous chorioretinopathy.
Comparison of half-dose photodynamic therapy and 689 nm laser treatment in eyes with chronic central serous chorioretinopathy.
Photodynamische Therapie mit halber Verteporfin-Dosis zur Behandlung der Chorioretinopathia Centralis Serosa.
One-year choroidal thickness results after photodynamic therapy for central serous chorioretinopathy.
[Evaluation of the choroid in central serous chorioretinopathy].
One-year results of reduced fluence photodynamic therapy for central serous chorioretinopathy: the outer nuclear layer thickness is associated with visual prognosis.
Efficacy of reduced-fluence photodynamic therapy for central serous chorioretinopathy associated with combined serous retinal detachment and fovea-involving pigment epithelial detachment.
Treatment and Monitoring of Central Serous Chorioretinopathy in Pilots.